Patent classifications
G01N33/64
METHOD AND APPARATUS FOR DETERMINING KETOSIS
An object of the present invention is to make it possible to easily determine a presence or absence of ketosis and/or the possibility of ketosis in an animal on site or the like. Another object of the present invention is to provide an apparatus for performing the determination. A method for determining ketosis according to one embodiment of the present invention includes providing gas detection means with a gas generated from a body fluid collected from an animal (except for humans), and determining ketosis of the animal based on a composition of the gas generated from the body fluid using a response of the gas detection means to the gas generated from the body fluid.
Ketone body concentration estimation device, method, and computer-readable storage medium
An acetone concentration estimate device acquires a measured acetone concentration measuring acetone excreted from a user, acquires an elapsed time which has elapsed since the user ate a meal, and estimates an acetone concentration, which is a ketone body concentration of when an amount of change in blood sugar level of the user per given unit of time is stable, based on the acquired current measured acetone concentration and on the acquired elapsed time, and outputs information corresponding to the estimated acetone concentration.
Ketone body concentration estimation device, method, and computer-readable storage medium
An acetone concentration estimate device acquires a measured acetone concentration measuring acetone excreted from a user, acquires an elapsed time which has elapsed since the user ate a meal, and estimates an acetone concentration, which is a ketone body concentration of when an amount of change in blood sugar level of the user per given unit of time is stable, based on the acquired current measured acetone concentration and on the acquired elapsed time, and outputs information corresponding to the estimated acetone concentration.
Breath analysis system with measurement tagging interface
A portable system is provided for measuring an analyte, such as acetone, in the breath or other bodily fluid of a user. The system includes a portable measurement device that analyzes fluid samples and generates corresponding measurements. The portable measurement device communicates with an application which runs on a smartphone or other mobile device of the user. The application tracks, and generates graphs of, the measurements, and may include various features for facilitating the analysis of the measurements.
Breath analysis system with measurement tagging interface
A portable system is provided for measuring an analyte, such as acetone, in the breath or other bodily fluid of a user. The system includes a portable measurement device that analyzes fluid samples and generates corresponding measurements. The portable measurement device communicates with an application which runs on a smartphone or other mobile device of the user. The application tracks, and generates graphs of, the measurements, and may include various features for facilitating the analysis of the measurements.
Non-invasive photonic sensing for monitoring diabetes
The present disclosure relates to a device (100) for monitoring a biomarker in an exhaled breath, the device (100) utilising a combination of a sensing element (110) having a thermochemical reactant (120) that undergoes a thermochemical reaction with the biomarker and a thermal sensor (140) positioned to measure a rate of change in temperature caused by the thermochemical reaction. A user interface (170) is provided for indicating to a user an indicated measure of the biomarker in the exhaled breath, wherein the indicated measure of the biomarker in the exhaled breath is determined from the measured rate of change in temperature.
Non-invasive photonic sensing for monitoring diabetes
The present disclosure relates to a device (100) for monitoring a biomarker in an exhaled breath, the device (100) utilising a combination of a sensing element (110) having a thermochemical reactant (120) that undergoes a thermochemical reaction with the biomarker and a thermal sensor (140) positioned to measure a rate of change in temperature caused by the thermochemical reaction. A user interface (170) is provided for indicating to a user an indicated measure of the biomarker in the exhaled breath, wherein the indicated measure of the biomarker in the exhaled breath is determined from the measured rate of change in temperature.
Breath analysis system
A portable system is provided for measuring an analyte, such as acetone, in the breath or other bodily fluid of a user. The system includes a portable measurement device that analyzes fluid samples and generates corresponding measurements. The portable measurement device communicates with an application which runs on a smartphone or other mobile device of the user, and the application reports measurement data to a remote system.
Breath analysis system
A portable system is provided for measuring an analyte, such as acetone, in the breath or other bodily fluid of a user. The system includes a portable measurement device that analyzes fluid samples and generates corresponding measurements. The portable measurement device communicates with an application which runs on a smartphone or other mobile device of the user, and the application reports measurement data to a remote system.
NONINVASIVE DETECTION OF CANCER ORIGINATING IN TISSUE OUTSIDE THE LUNG USING EXHALED BREATH
Provided is a non-invasive method of detecting or screening for a cancer in a subject specimen originating in a tissue outside of the lung. The method includes detecting elevated levels of one or more carbonyl-containing volatile organic compounds (VOCs) that are biomarkers for the cancer in exhaled breath from the subject specimen. The method may further include obtaining exhaled breath from the subject specimen; forming adducts of the carbonyl-containing VOCs with a reactive chemical compound; quantifying the adducts of the carbonyl-containing VOCs to establish a subject value for each of the adducts; and comparing each subject value to a threshold healthy specimen value for each of the adducts of the carbonyl-containing VOCs. One or more subject values at quantities greater than threshold healthy specimen values are also useful for screening for the cancer in the subject specimen.